CEACAM5 and medullary thyroid gland carcinoma: Lastly, a network meta-analysis comparing five different PET radiopharmaceuticals demonstrated that [18F]FDOPA PET/CT clearly showed the best performance for the detection of recurrent MTC in both patient- and lesion-based analyses regardless of serum Ctn or CEA levels and calcitonin doubling time [25].